Tag: UK
AstraZeneca announces third investment of Rs 176 crore in India
This commitment comes on the sidelines of Tamil Nadu Chief Minister visit to United Kingdom and aims to boost AstraZeneca’s Global Innovation & Technology Centre in Chennai focused on advancing technology & innovation efforts in healthcare
New India–UK trade deal opens billion-dollar channels in health, pharma &...
FTA unlocks zero-tariff access for Indian exports, sets stage for long-term collaboration in life sciences and digital health
India-UK meet on forest standards and traceability held at IIFM Bhopal
This workshop is part of the larger piece of work proposed to be delivered through India-UK PACT (Partnering for Accelerated Climate Transitions) on timber traceability and certification in agroforestry sector
Godavari Biorefineries’ anti-cancer patent secures key European validations
Anti-cancer patent now validated in Spain, the UK, and as a unitary patent covering multiple EU member states
UK biopharma venture financing QoQ doubles to $1.1 billion in Q1...
This surge highlights investor appetite for breakthrough innovation, but growing dependence on US capital and policy-driven cost pressures signal an urgent need to strengthen domestic investment
Fighting back against superbugs- A joint initiative by UK and India...
Researchers in the UK and India are collaborating to tackle the urgent issue of antibiotic overprescription by dentists
Lilly’s GBP279 million investment set to boost UK life sciences sector
As per GlobalData, the initiative is set to accelerate early-stage ventures and spearhead advancements in obesity treatments, invigorating the UK life sciences sector
TrioTree Technologies expands into Bahrain & Saudi Arabia to strengthen Middle...
e Technologies is one of the leading providers of healthcare solutions and hospital management in India, UK, the Middle East, GCC, Malaysia, Singapore, and Africa
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
OPPI welcomes Indian govt’s move to waive off local clinical trials...
This will be applicable to a few select drugs already approved in well-regulated markets like the USA, UK, Japan, Australia, Canada, and the EU